查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1388186

靜脈免疫球蛋白 (IVIG) 市場、份額、規模、趨勢、行業分析報告：按給藥途徑、按成分、按應用、按最終用戶、按分銷渠道、按地區、細分市場預測，2023-2032 年

Intravenous immunoglobulin Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Intravenous, Subcutaneous); By Component; By Application; By End-user; By Distribution Channel; By Region; Segment Forecast, 2023- 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris 市場研究的最新研究，到 2032 年，全球靜脈注射免疫球蛋白 (IVIG) 市場規模預計將達到 241.3 億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

血漿分離技術和製造過程的進步使靜脈注射免疫球蛋白 (IVIG) 產品更安全、更有效。 由於重組基因技術和純化方法，免疫球蛋白製劑現已高度純化和濃縮，減少了副作用的可能性並允許更精確的治療。 這些進展提高了 IVIG 對原發性免疫缺陷性疾病和某些自體免疫疾病的療效，為開發基於免疫球蛋白的新型療法改善患者預後創造了機會。 正在進行的研究揭示了神經系統疾病的新治療適應症，例如慢性發炎性脫髓鞘多發性神經炎、多灶性運動神經病變和重症肌無力。 擴大 IVIG 治療的疾病範圍將擴大基於免疫球蛋白的療法的市場潛力，使它們造福更多人。

由於 COVID-19 大流行，全球靜脈注射免疫球蛋白 (IVIG) 市場激增。 這項名為 "原發性和繼發性免疫缺陷患者中的COVID-19：英國經驗" 的研究於2020 年12 月進行，發現100 名患有症狀性繼發性免疫缺陷（SID）、原發性免疫缺陷（PID）和自體免疫缺陷等症狀的患者疾病C1抑制劑缺乏，70%感染SARS-CoV-2病毒，其中59%住院，8%死亡。 這凸顯了一個事實，即免疫功能低下的個體感染 COVID-19 的風險較高，預計將增加對靜脈注射免疫球蛋白療法來對抗這場流行病的需求。

靜脈注射免疫球蛋白 (IVIG) 市場報告亮點

預計 IgG 細分市場在預測期內將是最大的細分市場。 IgG 已在臨床試驗中廣泛研究，因此在醫學領域中廣泛使用和接受。 這些研究證明了 IgG 在治療各種自體免疫疾病、神經系統疾病和其他免疫相關疾病方面的有效性和安全性。

2022年，免疫缺陷領域佔據最大的市場份額。 免疫缺陷疾病分為兩種：原發性（遺傳性）和繼發性（後天性）。 原發性免疫缺陷通常是遺傳性的，從出生起就存在，而繼發性免疫缺陷可能由於感染、藥物和醫療程序等因素在以後的生活中出現。

到 2022 年，醫院的份額將最高。 醫院藥房監測接受 IVIG 治療的患者，與醫療保健專業人員合作追蹤患者的進展，並向監管機構報告任何不良事件或反應。

2022年，全球市場將由北美地區主導。 這是因為北美擁有高度發展的醫療基礎設施，支持該地區 IVIG 市場的成長。 由於癌症患者數量的不斷增加以及百特國際等大公司的存在，越來越多的有效藥物被引入市場。 此外，北美領先的製藥公司正在研發、臨床試驗和行銷策略方面進行大量投資，這正在推動 IVIG 市場的成長。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第四章全球靜脈注射免疫球蛋白 (IVIG) 市場洞察

  • 靜脈免疫球蛋白 (IVIG) - 產業概況
  • 靜脈免疫球蛋白 (IVIG) 市場動態
    • 推動者和機會
      • 患有免疫缺陷疾病的人數不斷增加
      • 採用基於免疫球蛋白的治療
    • 抑制因素和挑戰
      • 感染風險高，阻礙市場成長
  • 杵分析
  • 靜脈免疫球蛋白 (IVIG) 產業趨勢
  • COVID-19 感染的影響分析

第 5 章全球靜脈免疫球蛋白 (IVIG) 市場（按組成部分）

  • 主要發現
  • 簡介 IgG免疫球蛋白G
  • IgA
  • IgM
  • IgE
  • IgD

第 6 章全球靜脈免疫球蛋白 (IVIG) 市場（依給藥途徑）

  • 主要發現
  • 簡介
  • 靜脈注射
  • 皮下

第七章全球靜脈免疫球蛋白 (IVIG) 市場（依應用）

  • 主要發現
  • 簡介
  • 低丙種球蛋白血症
  • 慢性發炎性脫髓鞘多發性神經病變 (CIDP)
  • 免疫缺乏疾病
  • 重症肌無力
  • 多灶性運動神經病變
  • 特發性血小板減少性紫斑症（ITP）
  • 發炎性肌肉病變
  • 特異性抗體缺乏
  • 吉蘭-巴利症候群

第 8 章最終使用者全球靜脈免疫球蛋白 (IVIG) 市場

  • 主要發現
  • 簡介
  • 醫院
  • 家庭醫療護理
  • 專科診所

第 9 章全球靜脈免疫球蛋白 (IVIG) 市場（依通路）

  • 主要發現
  • 簡介
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 10 章按地區劃分的全球靜脈免疫球蛋白 (IVIG) 市場

  • 主要發現
  • 簡介
    • 2019-2032 年靜脈免疫球蛋白 (IVIG) 市場評估（按地區）
  • 靜脈注射免疫球蛋白 (IVIG) 市場 - 北美
    • 北美：靜脈免疫球蛋白 (IVIG) 市場，按組成部分，2019-2032 年
    • 北美：靜脈免疫球蛋白 (IVIG) 市場，按最終用戶劃分，2019-2032 年
    • 北美：靜脈免疫球蛋白 (IVIG) 市場（按給藥途徑），2019-2032 年
    • 北美：靜脈免疫球蛋白 (IVIG) 市場，按應用劃分，2019-2032 年
    • 北美：靜脈免疫球蛋白 (IVIG) 市場（依通路），2019-2032 年
    • 靜脈免疫球蛋白 (IVIG) 市場 - 美國
    • 靜脈免疫球蛋白 (IVIG) 市場 - 加拿大
  • 靜脈免疫球蛋白 (IVIG) 市場 - 歐洲
    • 歐洲：靜脈免疫球蛋白 (IVIG) 市場，按組成部分，2019-2032 年
    • 歐洲：靜脈免疫球蛋白 (IVIG) 市場，按最終用戶劃分，2019-2032 年
    • 歐洲：靜脈免疫球蛋白 (IVIG) 市場（按給藥途徑），2019-2032 年
    • 歐洲：靜脈免疫球蛋白 (IVIG) 市場，按應用劃分，2019-2032 年
    • 歐洲：靜脈免疫球蛋白 (IVIG) 市場（依通路），2019-2032 年
    • 靜脈免疫球蛋白 (IVIG) 市場 - 英國
    • 靜脈免疫球蛋白 (IVIG) 市場 - 法國
    • 靜脈免疫球蛋白 (IVIG) 市場 - 德國
    • 靜脈免疫球蛋白 (IVIG) 市場 - 義大利
    • 靜脈免疫球蛋白 (IVIG) 市場 - 西班牙
    • 靜脈免疫球蛋白 (IVIG) 市場 - 荷蘭
    • 靜脈免疫球蛋白市場 - 俄羅斯
  • 靜脈免疫球蛋白 (IVIG) 市場 - 亞太地區
    • 亞太地區：靜脈免疫球蛋白 (IVIG) 市場，依組成部分，2019-2032 年
    • 亞太地區：靜脈免疫球蛋白 (IVIG) 市場，按最終用戶劃分，2019-2032 年
    • 亞太地區：靜脈免疫球蛋白 (IVIG) 市場（按給藥途徑），2019-2032 年
    • 亞太地區：靜脈免疫球蛋白 (IVIG) 市場，依應用劃分，2019-2032 年
    • 亞太地區：靜脈免疫球蛋白 (IVIG) 市場（依通路），2019-2032 年
    • 靜脈注射免疫球蛋白 (IVIG) 市場 - 中國
    • 靜脈免疫球蛋白 (IVIG) 市場 - 印度
    • 靜脈免疫球蛋白 (IVIG) 市場 - 日本
    • 靜脈免疫球蛋白 (IVIG) 市場 - 馬來西亞
    • 靜脈免疫球蛋白 (IVIG) 市場 - 印度尼西亞
    • 靜脈免疫球蛋白 (IVIG) 市場 - 韓國
  • 靜脈免疫球蛋白 (IVIG) 市場 – 中東和非洲
    • 中東和非洲：靜脈免疫球蛋白 (IVIG) 市場（按組成部分），2019-2032 年
    • 中東和非洲：靜脈免疫球蛋白 (IVIG) 市場，按最終用戶劃分，2019-2032 年
    • 中東和非洲：靜脈免疫球蛋白 (IVIG) 市場，按給藥途徑劃分，2019-2032 年
    • 中東和非洲：靜脈免疫球蛋白 (IVIG) 市場，按應用劃分，2019-2032 年
    • 中東和非洲：靜脈免疫球蛋白 (IVIG) 市場（按分銷管道），2019-2032 年
    • 靜脈免疫球蛋白 (IVIG) 市場 - 沙烏地阿拉伯
    • 靜脈免疫球蛋白 (IVIG) 市場 - 阿聯酋
    • 靜脈免疫球蛋白 (IVIG) 市場 - 以色列
    • 靜脈免疫球蛋白 (IVIG) 市場 - 南非
  • 靜脈免疫球蛋白 (IVIG) 市場 - 拉丁美洲
    • 拉丁美洲：靜脈免疫球蛋白 (IVIG) 市場，按組成部分，2019-2032 年
    • 拉丁美洲：靜脈免疫球蛋白 (IVIG) 市場，按最終用戶劃分，2019-2032 年
    • 拉丁美洲：靜脈免疫球蛋白 (IVIG) 市場，依給藥途徑劃分，2019-2032 年
    • 拉丁美洲：靜脈免疫球蛋白 (IVIG) 市場，按應用劃分，2019-2032 年
    • 拉丁美洲：靜脈免疫球蛋白 (IVIG) 市場（按分銷管道），2019-2032 年
    • 靜脈免疫球蛋白 (IVIG) 市場 - 墨西哥
    • 靜脈免疫球蛋白 (IVIG) 市場 - 巴西
    • 靜脈免疫球蛋白 (IVIG) 市場 - 阿根廷

第十一章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第十二章公司簡介

  • Baxter International Inc.
  • BDI Pharma Inc.
  • Biotest AG
  • China Biologics Products Inc.
  • CSL Behring
  • Grifols SA
  • Kedrion Biopharma
  • LFB Biotechnologies
  • Octapharma AG
Product Code: PM1297

The global intravenous immunoglobulin market size is expected to reach USD 24.13 billion by 2032, according to a new study by Polaris market research. The report "Intravenous immunoglobulin Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Intravenous, Subcutaneous); By Component; By Application; By End-user; By Distribution Channel; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Advancements in plasma fractionation techniques and manufacturing processes have made Intravenous Immunoglobulin (IVIG) products safer and more effective. Thanks to recombinant technologies and purification methods, immunoglobulin products are now highly refined and concentrated, which reduces the chance of adverse reactions and enables more precise therapies. These developments have improved the efficacy of IVIG for primary immune deficiencies, certain autoimmune disorders, and created opportunities for developing novel immunoglobulin-based treatments that can improve patient outcomes. Ongoing research has revealed new therapeutic indications for neurological conditions such as chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, and myasthenia gravis. The expansion of symptoms treated with IVIG provides a wider market potential for immunoglobulin-based therapies, which can benefit more people.

The global market for intravenous immunoglobulin saw a surge due to the COVID-19 pandemic. Research conducted in December 2020, named "COVID-19 in patients with primary and secondary immunodeficiency: The U.K. experience", found that 70% out of 100 people with symptomatic secondary immunodeficiency (SID), primary immunodeficiency (PID), autoinflammatory diseases, and C1 inhibitor deficiency were infected with the SARS-CoV-2 virus and 59% of them were admitted to hospitals, with 8% of them losing their lives. This highlights the fact that immunocompromised individuals are at a higher risk of getting COVID-19, leading to an expected increase in the demand for intravenous immunoglobulin therapy to combat the pandemic.

Virtual trials offer numerous advantages, including remote data collection, increased participant engagement, and larger population inclusion. They minimize risks associated with in-person visits and reduce the burden on participants, coordinators, and investigators. By leveraging virtual methods, the clinical trials industry can overcome challenges, improve efficiency, and facilitate prompt and effective data collection.

Intravenous immunoglobulin Market Report Highlights

During the forecast period, the IgG segment is expected to be the largest. IgG has been extensively researched in clinical trials, which has resulted in its widespread use and acceptance in the medical field. These studies have demonstrated IgG's efficacy and safety in treating various autoimmune disorders, neurological conditions, and other immune-related diseases.

The immunodeficiency diseases segment held the largest market share in 2022. Immunodeficiency diseases can be categorized into two types: primary (inherited) and secondary (acquired). Primary immunodeficiencies are typically genetic and present from birth, while secondary immunodeficiencies can develop later in life due to factors such as infections, medications, or medical treatments.

Hospitals accounted for the highest share in 2022. Hospital pharmacies monitor patients receiving IVIG therapy, collaborate with healthcare professionals to track patient progress, and report any adverse events or reactions to regulatory bodies.

In 2022, the global market was dominated by the North America region. This is because North America has a highly advanced healthcare infrastructure that supports the growth of the IVIG market in the region. With a rising number of cancer patients and the presence of key players such as Baxter International Inc., effective drugs are increasingly being introduced into the market. Furthermore, major pharmaceutical companies in North America invest heavily in research and development, clinical trials, and marketing strategies, which in turn drives the growth of the IVIG market.

The global key market players include: Baxter International Inc., BDI Pharma Inc., Biotest AG, China Biologics Products Inc., CSL Behring, Grifols SA, Kedrion Biopharma, LFB Biotechnologies, Octapharma AG

Polaris market research has segmented the Intravenous immunoglobulin market report based on component, route of administration, application, end-users, distribution channel and region:

Intravenous immunoglobulin, Component Outlook (Revenue - USD Billion, 2019 - 2032)

  • IGG
  • IGA
  • IGM
  • IGE
  • IGD

Intravenous immunoglobulin, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Intravenous
  • Subcutaneous

Intravenous immunoglobulin, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hypogammaglobulinemia
  • Chronic Inflammatory demyelinating polyneuropathy (CIDP)
  • Immunodeficiency diseases
  • Myasthenia Gravis
  • Multifocal motor neuropathy
  • Idiopathic thrombocytopenic purpura (ITP)
  • Inflammatory myopathies
  • Specific antibody deficiency
  • Guillain-Barre syndrome

Intravenous immunoglobulin, End-Users Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Homecare
  • Specialty Clinics

Intravenous immunoglobulin, Distribution channels Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies

Intravenous immunoglobulin, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Intravenous Immunoglobulin Market Insights

  • 4.1. Intravenous immunoglobulin - Industry Snapshot
  • 4.2. Intravenous immunoglobulin Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. The number of people suffering from immunodeficiency disorders is on the rise.to drive the market growth
      • 4.2.1.2. Adoption of immunoglobulin-based therapies, drive the market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High risk of transmission, hinder the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Intravenous immunoglobulin Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Intravenous immunoglobulin Market, by Component

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Intravenous Immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • 5.3. IGG
    • 5.3.1. Global Intravenous Immunoglobulin Market, by IGG, by Region, 2019-2032 (USD Billion)
  • 5.4. IGA
    • 5.4.1. Global Intravenous Immunoglobulin Market, by IGA, by Region, 2019-2032 (USD Billion)
  • 5.5. IGM
    • 5.5.1. Global Intravenous Immunoglobulin Market, by IGM, by Region, 2019-2032 (USD Billion)
  • 5.6. IGE
    • 5.6.1. Global Intravenous Immunoglobulin Market, by IGE, by Region, 2019-2032 (USD Billion)
  • 5.7. IGD
    • 5.7.1. Global Intravenous Immunoglobulin Market, by IGD, by Region, 2019-2032 (USD Billion)

6. Global Intravenous immunoglobulin Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Intravenous
    • 6.3.1. Global Intravenous immunoglobulin Market, by Intravenous, by Region, 2019-2032 (USD Billion)
  • 6.4. Subcutaneous
    • 6.4.1. Global Intravenous immunoglobulin Market, by Subcutaneous, by Region, 2019-2032 (USD Billion)

7. Global Intravenous immunoglobulin Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Hypogammaglobulinemia
    • 7.3.1. Global Intravenous immunoglobulin Market, by Hypogammaglobulinemia, by Region, 2019-2032 (USD Billion)
  • 7.4. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
    • 7.4.1. Global Intravenous immunoglobulin Market, by Chronic Inflammatory demyelinating polyneuropathy (CIDP), by Region, 2019-2032 (USD Billion)
  • 7.5. Immunodeficiency diseases
    • 7.5.1. Global Intravenous immunoglobulin Market, by Immunodeficiency diseases, by Region, 2019-2032 (USD Billion)
  • 7.6. Myasthenia Gravis
    • 7.6.1. Global Intravenous immunoglobulin Market, by Myasthenia Gravis, by Region, 2019-2032 (USD Billion)
  • 7.7. Multifocal motor neuropathy
    • 7.7.1. Global Intravenous immunoglobulin Market, by Multifocal motor neuropathy, by Region, 2019-2032 (USD Billion)
  • 7.8. Idiopathic thrombocytopenic purpura (ITP)
    • 7.8.1. Global Intravenous immunoglobulin Market, by Idiopathic thrombocytopenic purpura (ITP), by Region, 2019-2032 (USD Billion)
  • 7.9. Inflammatory myopathies
    • 7.9.1. Global Intravenous immunoglobulin Market, by Inflammatory myopathies, by Region, 2019-2032 (USD Billion)
  • 7.10. Specific antibody deficiency
    • 7.10.1. Global Intravenous immunoglobulin Market, by Specific antibody deficiency, by Region, 2019-2032 (USD Billion)
  • 7.11. Guillain-Barre syndrome
    • 7.11.1. Global Intravenous immunoglobulin Market, by Guillain-Barre syndrome, by Region, 2019-2032 (USD Billion)

8. Global Intravenous immunoglobulin Market, by End Users

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Intravenous immunoglobulin Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 8.4. Homecare
    • 8.4.1. Global Intravenous immunoglobulin Market, by Homecare, by Region, 2019-2032 (USD Billion)
  • 8.5. Specialty Clinics
    • 8.5.1. Global Intravenous immunoglobulin Market, by Specialty Clinics, by Region, 2019-2032 (USD Billion)

9. Global Intravenous immunoglobulin Market, by Distribution Channel

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 9.3. Hospital Pharmacy
    • 9.3.1. Global Intravenous immunoglobulin Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)
  • 9.4. Retail Pharmacy
    • 9.4.1. Global Intravenous immunoglobulin Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)
  • 9.5. Online Pharmacies
    • 9.5.1. Global Intravenous immunoglobulin Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)

10. Global Intravenous immunoglobulin Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Intravenous immunoglobulin Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Intravenous immunoglobulin Market - North America
    • 10.3.1. North America: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
    • 10.3.2. North America: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
    • 10.3.3. North America: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.3.4. North America: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
    • 10.3.5. North America: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.3.6. Intravenous immunoglobulin Market - U.S.
      • 10.3.6.1. U.S.: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.3.7. Intravenous immunoglobulin Market - Canada
      • 10.3.7.1. Canada: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 10.4. Intravenous immunoglobulin Market - Europe
    • 10.4.1. Europe: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.6. Intravenous immunoglobulin Market - UK
      • 10.4.6.1. UK: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.7. Intravenous immunoglobulin Market - France
      • 10.4.7.1. France: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.8. Intravenous immunoglobulin Market - Germany
      • 10.4.8.1. Germany: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.9. Intravenous immunoglobulin Market - Italy
      • 10.4.9.1. Italy: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.10. Intravenous immunoglobulin Market - Spain
      • 10.4.10.1. Spain: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.11. Intravenous immunoglobulin Market - Netherlands
      • 10.4.11.1. Netherlands: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.12. Intravenous immunoglobulin Market - Russia
      • 10.4.12.1. Russia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 10.5. Intravenous immunoglobulin Market - Asia Pacific
    • 10.5.1. Asia Pacific: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.6. Intravenous immunoglobulin Market - China
      • 10.5.6.1. China: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.7. Intravenous immunoglobulin Market - India
      • 10.5.7.1. India: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.8. Intravenous immunoglobulin Market - Japan
      • 10.5.8.1. Japan: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.9. Intravenous immunoglobulin Market - Malaysia
      • 10.5.9.1. Malaysia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.10. Intravenous immunoglobulin Market - Indonesia
      • 10.5.10.1. Indonesia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.11. Intravenous immunoglobulin Market - South Korea
      • 10.5.11.1. South Korea: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 10.6. Intravenous immunoglobulin Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.6.6. Intravenous immunoglobulin Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.6.7. Intravenous immunoglobulin Market - UAE
      • 10.6.7.1. UAE: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.6.8. Intravenous immunoglobulin Market - Israel
      • 10.6.8.1. Israel: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.6.9. Intravenous immunoglobulin Market - South Africa
      • 10.6.9.1. South Africa: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 10.7. Intravenous immunoglobulin Market - Latin America
    • 10.7.1. Latin America: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.7.6. Intravenous immunoglobulin Market - Mexico
      • 10.7.6.1. Mexico: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.7.7. Intravenous immunoglobulin Market - Brazil
      • 10.7.7.1. Brazil: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.7.8. Intravenous immunoglobulin Market - Argentina
      • 10.7.8.1. Argentina: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Baxter International Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. BDI Pharma Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Biotest AG
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. China Biologics Products Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. CSL Behring
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Grifols SA
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Kedrion Biopharma
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. LFB Biotechnologies
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Octapharma AG
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development

List of Tables

  • Table 1 Global Intravenous immunoglobulin Market, by Component, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Intravenous immunoglobulin Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Intravenous immunoglobulin Market, by Application, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Intravenous immunoglobulin Market, by Distribution Channel, by Region, 2019-2032 (USD Billion)
  • Table 5 Global Intravenous immunoglobulin Market, by End Users, by Region, 2019-2032 (USD Billion)
  • Table 6 North America: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 7 North America: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 8 North America: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 9 North America: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 North America: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 11 U.S.: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 12 U.S.: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 13 U.S.: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 14 U.S.: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 15 U.S.: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 16 Canada: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 17 Canada: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 18 Canada: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 19 Canada: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 20 Canada: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 21 Europe: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 22 Europe: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 23 Europe: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 24 Europe: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 25 Europe: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 26 Germany: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 27 Germany: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 Germany: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Germany: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 30 Germany: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 31 France: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 32 France: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 33 France: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 34 France: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 France: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 36 UK: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 37 UK: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 38 UK: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 39 UK: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 40 UK: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 41 Italy: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 42 Italy: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 43 Italy: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 44 Italy: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 45 Italy: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 46 Netherlands: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 47 Netherlands: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 48 Netherlands: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Netherlands: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Netherlands: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 51 Spain: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 52 Spain: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 53 Spain: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 54 Spain: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 Spain: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 56 Russia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 57 Russia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 58 Russia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 59 Russia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 60 Russia: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 61 Asia Pacific: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 62 Asia Pacific: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 63 Asia Pacific: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Asia Pacific: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 65 Asia Pacific: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 66 China: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 67 China: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 68 China: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 69 China: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 China: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 71 Japan: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 72 Japan: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 73 Japan: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 74 Japan: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 75 Japan: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 76 India: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 77 India: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 78 India: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 79 India: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 80 India: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 81 Indonesia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 82 Indonesia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 83 Indonesia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 84 Indonesia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 85 Indonesia: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 86 Malaysia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 87 Malaysia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 88 Malaysia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 89 Malaysia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 90 Malaysia: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 91 South Korea: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 92 South Korea: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 93 South Korea: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 94 South Korea: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 95 South Korea: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 96 Latin America: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 97 Latin America: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 98 Latin America: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 99 Latin America: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 100 Latin America: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 101 Brazil: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 102 Brazil: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 103 Brazil: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 104 Brazil: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 105 Brazil: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 106 Mexico: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 107 Mexico: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 108 Mexico: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 109 Mexico: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 110 Mexico: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 111 Argentina: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 112 Argentina: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 113 Argentina: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 114 Argentina: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 115 Argentina: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 116 Middle East & Africa: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 117 Middle East & Africa: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 118 Middle East & Africa: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 119 Middle East & Africa: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 120 Middle East & Africa: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 121 UAE: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 122 UAE: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 123 UAE: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 124 UAE: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 125 UAE: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 126 Saudi Arabia: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 127 Saudi Arabia: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 128 Saudi Arabia: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 129 Saudi Arabia: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 130 Saudi Arabia: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 131 South Africa: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 132 South Africa: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 133 South Africa: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 134 South Africa: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 135 South Africa: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)
  • Table 136 Israel: Intravenous immunoglobulin Market, by Component, 2019-2032 (USD Billion)
  • Table 137 Israel: Intravenous immunoglobulin Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 138 Israel: Intravenous immunoglobulin Market, by Application, 2019-2032 (USD Billion)
  • Table 139 Israel: Intravenous immunoglobulin Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 140 Israel: Intravenous immunoglobulin Market, by End Users, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Intravenous immunoglobulin Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Component
  • Figure 7. Global Intravenous immunoglobulin Market, by Component, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Route of Administration
  • Figure 9. Global Intravenous immunoglobulin Market, by Route of Administration, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Intravenous immunoglobulin Market, by Application, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Distribution Channel
  • Figure 13. Global Intravenous immunoglobulin Market, by Distribution Channel, 2021 & 2030 (USD Billion)
  • Figure 14. Market by End Users
  • Figure 15. Global Intravenous immunoglobulin Market, by End Users, 2021 & 2030 (USD Billion)